DBV Technologies S.A.
$18.56+0.30%(+$0.05)
TickerSpark Score
46/100
60
Valuation
20
Profitability
15
Growth
76
Health
60
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DBVT research report →
52-Week Range59% of range
Low $7.53
Current $18.56
High $26.18
Companywww.dbv-technologies.com
DBV Technologies S. A. , a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products.
- CEO
- Daniel Tassé
- IPO
- 2014
- Employees
- 106
- HQ
- Montrouge, FR
Price Chart
+93.38% · this period
Valuation
- Market Cap
- $444.10M
- P/E
- -9.62
- P/S
- 0.00
- P/B
- 7.76
- EV/EBITDA
- -2.62
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -130.06%
- ROIC
- -74.64%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-146,947,000 · -29.22%
- EPS
- $-1.70 · -41.67%
- Op Income
- $-147,056,000
- FCF YoY
- -13.45%
Performance & Tape
- 52W High
- $26.18
- 52W Low
- $7.53
- 50D MA
- $20.28
- 200D MA
- $16.78
- Beta
- -0.24
- Avg Volume
- 233.52K
Get TickerSpark's AI analysis on DBVT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Start Free Trial →Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 30, 25 | Lee Philina | other | 0 |
| Jan 29, 26 | Mohideen Pharis | sell | 534 |
| Jan 12, 26 | BAKER BROS. ADVISORS LP | other | 25,005,240 |
| Jan 12, 26 | BAKER BROS. ADVISORS LP | other | 2,299,656 |
| Jan 12, 26 | BAKER BROS. ADVISORS LP | other | 25,005,240 |
| Dec 17, 25 | EPIC Bpifrance | sell | 2,036,990 |
| Dec 17, 25 | EPIC Bpifrance | sell | 40,000 |
| Dec 18, 25 | EPIC Bpifrance | sell | 1,292,103 |
| Nov 21, 25 | Mohideen Pharis | other | 253,000 |
| Nov 21, 25 | Mohideen Pharis | other | 44,000 |
Our DBVT Coverage
We haven't published any research on DBVT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate DBVT Report →